<a href="https://www.bioagilytix.com/blog/category/drug-development/">Drug Development</a>
GLP-1 and Metabolic Peptide Therapeutics: Bioanalytical Strategy is a Key Factor in Drug Development
The GLP-1 revolution has reshaped the metabolic disease landscape, and the pipeline behind semaglutide and tirzepatide continues to expand at an unprecedented pace. Sponsors are…
<a href="https://www.bioagilytix.com/blog/category/drug-development/">Drug Development</a>
Are We Closer to Using the Word “Cures” More Often?
As we look towards the development of the next generation of drugs and therapies, it starts to beg the question of whether we are creating…